Menu Menu

MRSN    Mersana Therapeutics Inc    1442836    
Income Statement
Revenue mrsn-20241231 40,497,000
Net Income mrsn-20241231 -69,192,000
Profit Margin -170.86%

Balance Sheet
Current Assets 136,904,000
Assets 144,663,000
Current Liabilities 62,458,000
Liabilities 154,172,000
Equity -9,509,000

Cash Flow Statement
Operating Cash Flow -82,340,000
Investing Cash Flow 11,437,000

Market Analysis
BVPS 18.77
PB 0.02
PS 1.56
FCF -70,903,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/28 -0.16 3/3 -0.56
Apr May Jun
5/09 -0.16
Jul Aug Sep
8/13 -0.20
Oct Nov Dec
11/12

Find a discrepancy? The most accurate way to find company fundamental data is to view MRSN documents filed with the SEC.


MRSN Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas